<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7499567\results\search\disease\results.xml">
  <result pre="AcademicSubjects/SCI01150AcademicSubjects/MED00690: Mini Review The past, present and future of RNA" exact="respiratory" post="viruses: influenza and coronaviruses MakarovVadim[], Federal Research Center Fundamentals"/>
  <result pre="coronaviruses MakarovVadim[], Federal Research Center Fundamentals of Biotechnology of the" exact="Russian" post="Academy of SciencesRussiaRiabovaOlga[], Federal Research Center Fundamentals of Biotechnology"/>
  <result pre="of SciencesRussiaRiabovaOlga[], Federal Research Center Fundamentals of Biotechnology of the" exact="Russian" post="Academy of SciencesRussiaEkinsSean[], Collaborations Pharmaceuticals, Inc.USAPluzhnikovNikolay[], State Research Institute"/>
  <result pre="of Military Medicine of the Ministry of Defence of the" exact="Russian" post="FederationRussiaChepurSergei[], State Research Institute of Military Medicine of the"/>
  <result pre="of Military Medicine of the Ministry of Defence of the" exact="Russian" post="FederationRussia Corresponding authors: FRC Fundamentals of Biotechnology RAS, Leninsky"/>
  <result pre="thoughts about what we need to do to prepare for" exact="respiratory" post="viral threats in the future. Influenza virus and coronaviruses"/>
  <result pre="about what we need to do to prepare for respiratory" exact="viral" post="threats in the future. Influenza virus and coronaviruses continue"/>
  <result pre="INTRODUCTION With regularity we face previously unknown strains of virulent" exact="respiratory" post="viruses that are life-threatening for large numbers of people."/>
  <result pre="is generally thought that the first large outbreak of a" exact="respiratory" post="infection with clinical symptoms similar to those of influenza"/>
  <result pre="generally thought that the first large outbreak of a respiratory" exact="infection" post="with clinical symptoms similar to those of influenza was"/>
  <result pre="Falagas 2008). Next, a detailed written report of an epidemic" exact="respiratory" post="disease similar to influenza was noted in England and"/>
  <result pre="2008). Next, a detailed written report of an epidemic respiratory" exact="disease" post="similar to influenza was noted in England and named"/>
  <result pre="Daly, Gustafson and Kendall 2007). In the 16th century, this" exact="infection" post="was named influenza (from the Latin influentia, influence), as"/>
  <result pre="was named influenza (from the Latin influentia, influence), as this" exact="disease" post="was considered a bad influence from the heavens (Broxmeyer"/>
  <result pre="targeted search for pathogens able to produce an epidemic/pandemic of" exact="acute" post="respiratory infections started in the late 19th century (PfeifferÂ"/>
  <result pre="search for pathogens able to produce an epidemic/pandemic of acute" exact="respiratory" post="infections started in the late 19th century (PfeifferÂ 1893;"/>
  <result pre="for pathogens able to produce an epidemic/pandemic of acute respiratory" exact="infections" post="started in the late 19th century (PfeifferÂ 1893; Olitsky"/>
  <result pre="etÂ al. 2013). Until recently, it was thought that coronavirus" exact="infections" post="with symptoms of the common cold cause between 15%"/>
  <result pre="of the common cold cause between 15% and 35% seasonal" exact="acute" post="respiratory diseases. Children become infected at a rate of"/>
  <result pre="the common cold cause between 15% and 35% seasonal acute" exact="respiratory" post="diseases. Children become infected at a rate of five"/>
  <result pre="al. 1970; Callow etÂ al. 1990; Holmes 2001). In humans," exact="respiratory" post="infections can be caused by two species of Î±-coronaviruses"/>
  <result pre="1970; Callow etÂ al. 1990; Holmes 2001). In humans, respiratory" exact="infections" post="can be caused by two species of Î±-coronaviruses (229E"/>
  <result pre="have known for a long time that coronaviruses cause fatal" exact="respiratory" post="and gastrointestinal infections in animals (Pensaert 1999). Coronaviruses were"/>
  <result pre="a long time that coronaviruses cause fatal respiratory and gastrointestinal" exact="infections" post="in animals (Pensaert 1999). Coronaviruses were only recently acknowledged"/>
  <result pre="appeared, which are frequently fatal for humans. These include severe" exact="acute" post="respiratory syndrome-related coronavirus (SARS-CoV, which occurred from 2002 to"/>
  <result pre="which are frequently fatal for humans. These include severe acute" exact="respiratory" post="syndrome-related coronavirus (SARS-CoV, which occurred from 2002 to 2004),"/>
  <result pre="coronavirus (SARS-CoV, which occurred from 2002 to 2004), Middle East" exact="respiratory" post="syndrome-related coronavirus (MERS-CoV, which was identified in 2012) and"/>
  <result pre="which was identified in 2012) and most recently the new" exact="pneumonia" post="coronavirus (SARS-CoV-2, which is the ongoing outbreak that was"/>
  <result pre="(TableÂ 2). In all cases, these three viruses cause severe" exact="bronchiolitis" post="and pneumonia, often with fatal outcomes (Cherry 2004; Ramadan"/>
  <result pre="(hundreds) 2002â€&quot;2004 SARS outbreak 2002â€&quot;2004 SARS-CoV-1 774 2012 Middle East" exact="respiratory" post="syndrome coronavirus outbreak 2012â€&quot;present MERS-CoV 862 (as of 13"/>
  <result pre="2002â€&quot;2004 SARS outbreak 2002â€&quot;2004 SARS-CoV-1 774 2012 Middle East respiratory" exact="syndrome" post="coronavirus outbreak 2012â€&quot;present MERS-CoV 862 (as of 13 January"/>
  <result pre="were for the first time isolated from a patient with" exact="acute" post="respiratory diseases in 1965 (Hamre and Procknow 1966; Tyrrell"/>
  <result pre="for the first time isolated from a patient with acute" exact="respiratory" post="diseases in 1965 (Hamre and Procknow 1966; Tyrrell and"/>
  <result pre="for most scientists. It is apparent that pandemic outbreaks of" exact="respiratory" post="viral infections represented a danger for humanity in the"/>
  <result pre="most scientists. It is apparent that pandemic outbreaks of respiratory" exact="viral" post="infections represented a danger for humanity in the past,"/>
  <result pre="scientists. It is apparent that pandemic outbreaks of respiratory viral" exact="infections" post="represented a danger for humanity in the past, and"/>
  <result pre="a new pandemic as well as the virulence of pandemic" exact="viral" post="strains. However, there are certain factors that increase the"/>
  <result pre="one type of eponymous virus. It is understood that only" exact="type A" post="viruses have pandemic potential (Bouvier and Palese 2008; Spickler"/>
  <result pre="the antigenic properties of hemagglutinin (HA; a glycoprotein of the" exact="viral" post="envelope that ensures the recognition of target cells and"/>
  <result pre="that ensures the recognition of target cells and binding of" exact="viral" post="particles to the terminal residues of sialic acids of"/>
  <result pre="of sialic acids of the glycoproteins of plasma membranes of" exact="epithelial" post="cells) and neuraminidase (NA; exo-Î±-sialidase catalyzing the splitting of"/>
  <result pre="use the cellular splicing machinery to form splice variants of" exact="viral" post="mRNA(messenger RiboNucleuc Acid). In addition, to widen their proteome,"/>
  <result pre="are probably using alternative open reading frames. Figure 1. (A)" exact="Structural" post="elements of the influenza A virus. (B) Structural elements"/>
  <result pre="1. (A) Structural elements of the influenza A virus. (B)" exact="Structural" post="elements of the coronavirus (based on betacoronavirus subgroup A)."/>
  <result pre="elements of the coronavirus (based on betacoronavirus subgroup A). Most" exact="viral" post="proteins are located inside the lipid envelope, while only"/>
  <result pre="projections (Neuman etÂ al. 2006; BÃ¡rcena etÂ al. 2009). The" exact="viral" post="envelope is made of a bilipid layer where S,"/>
  <result pre="provide the interaction of the virion with the receptors of" exact="epithelial" post="cells followed by the internalization of the viral genome"/>
  <result pre="receptors of epithelial cells followed by the internalization of the" exact="viral" post="genome (Li 2016). The S protein also is known"/>
  <result pre="this glycoprotein ensure the correct assembly and formation of a" exact="viral" post="particle (Neuman etÂ al. 2011). The E protein is"/>
  <result pre="namely, in virion assembly, envelope forming and release of a" exact="viral" post="particle from the cell. There is indirect evidence that"/>
  <result pre="protein present inside the virion; it is responsible for the" exact="viral" post="genome packaging (McBride, van Zyl and Fielding 2014). The"/>
  <result pre="(Leung etÂ al. 2012; Byrd-Leotis, Cummings and Steinhauer 2017). When" exact="viral" post="HA binds sialic glycoproteins or glycolipids on the plasma"/>
  <result pre="sialic glycoproteins or glycolipids on the plasma membrane of an" exact="epithelial" post="cell, this results in the initiation of several mechanisms"/>
  <result pre="to the formation of endosomes, each of which contains a" exact="viral" post="particle (Chardonnet and Dales 1970; Matlin etÂ al. 1981;"/>
  <result pre="next step of the internalization is the release of the" exact="viral" post="genome (RNA segments) into the cellular cytoplasm; this phase"/>
  <result pre="endosomes, helps the tetramers of the M2 protein of the" exact="viral" post="envelop to realize its potential as a protonophore (Sugrue"/>
  <result pre="Manzoor, Igarashi and Takada 2017). When hydrogen ions enter a" exact="viral" post="particle, it mediates conformational changes and decomposition of the"/>
  <result pre="conformational changes and decomposition of the structural components of the" exact="viral" post="envelope, which finally leads to an increase in the"/>
  <result pre="1983; Yoshimura and Ohnishi 1984). However, the fusion of the" exact="viral" post="envelope membrane and the endosomal membrane, which releases the"/>
  <result pre="cellular cytoplasm, is possible only with the participation of the" exact="viral" post="HA after the previous proteolytic processing with serine (secretory"/>
  <result pre="al. 2008). The translocation of RNA segments of the influenza" exact="viral" post="genome from the cytoplasm to the nucleus is necessary"/>
  <result pre="to the nucleus is necessary for their replication, during which" exact="viral" post="mRNA exits the nucleus to synthetize viral proteins in"/>
  <result pre="replication, during which viral mRNA exits the nucleus to synthetize" exact="viral" post="proteins in the cytoplasm. The viral self-assembly takes place"/>
  <result pre="the nucleus to synthetize viral proteins in the cytoplasm. The" exact="viral" post="self-assembly takes place at the apical surface of the"/>
  <result pre="place at the apical surface of the plasma membrane of" exact="epithelial" post="cells, where HA and NA molecules are concentrated (Samji"/>
  <result pre="S protein (widely known as the spike protein) of the" exact="viral" post="envelope. The S protein of a coronavirus is a"/>
  <result pre="a highly glycosylated supramolecular structure that enables the fixation of" exact="viral" post="particles on the plasma membrane of epithelial cells, followed"/>
  <result pre="the fixation of viral particles on the plasma membrane of" exact="epithelial" post="cells, followed by the release of their RNA into"/>
  <result pre="domains interact with either specific proteins or sialoglycans of the" exact="epithelial" post="cells (Li 2012; Shahwan etÂ al. 2013; Hulswit etÂ"/>
  <result pre="(Ou etÂ al. 2020). After that, the internalization of the" exact="viral" post="genome may proceed by endocytosis of the virion (which"/>
  <result pre="of a coronaviral envelope with the plasma membrane of an" exact="epithelial" post="cell, without the formation of endosomes (directly on the"/>
  <result pre="the plasma membrane). In any case, the release of the" exact="viral" post="RNA into the cellular cytoplasm is preceded by the"/>
  <result pre="2014; Zumla etÂ al. 2016). In the cytoplasm of an" exact="epithelial" post="cell, the viral RNA genome functions as mRNA, where"/>
  <result pre="al. 2016). In the cytoplasm of an epithelial cell, the" exact="viral" post="RNA genome functions as mRNA, where the complex of"/>
  <result pre="both RNA genome replication and synthesis of mRNA of structural" exact="viral" post="proteins (Sola etÂ al. 2015; Nakagawa, Lokugamage and Makino"/>
  <result pre="coronaviral proteins enter the cytoplasm and ensure the self-assembly of" exact="viral" post="particles. The latter particles migrate to the cellular membrane"/>
  <result pre="modulate the profile of glycosylation of proteins and lipids of" exact="epithelial" post="cells and viruses, as well as control the activity"/>
  <result pre="well as control the activity of serine proteases on the" exact="epithelial" post="lining of respiratory ways, may significantly limit the virulence"/>
  <result pre="the activity of serine proteases on the epithelial lining of" exact="respiratory" post="ways, may significantly limit the virulence of influenza viruses"/>
  <result pre="in the formation of quasi-subtypes (immunologically different antigenic variants) of" exact="type A" post="viruses (Barbezange etÂ al. 2018). This biological characteristic is"/>
  <result pre="genome replication (300 times higher than during the replication of" exact="bacterial" post="DNA genome) (Drake 1993). Another distinctive characteristic is the"/>
  <result pre="distinctive characteristic is the high mutational tolerance of glycoproteins of" exact="viral" post="envelopes, i.e. the ability of HA and NA to"/>
  <result pre="their functional activity in case of significant changes in the" exact="primary" post="structure of the polypeptide chain (Thyagarajan and Bloom 2014;"/>
  <result pre="The antigenic shift is the interchange of RNA segments of" exact="viral" post="genome that code the HA and/or NA structure in"/>
  <result pre="code the HA and/or NA structure in case of simultaneous" exact="infection" post="of a cell by several strains of the influenza"/>
  <result pre="sudden appearance of new virulent pandemic strains. PANDEMIC RESPIRATORY VIRAL" exact="INFECTIONS" post="AND THE PROBLEM OF PNEUMONIA The influenza pandemic in"/>
  <result pre="Mueller 2002). The mortality during pandemics of influenza and coronaviral" exact="infections" post="is largely associated with pneumonia (Morens, Taubenberger and Fauci"/>
  <result pre="pandemics of influenza and coronaviral infections is largely associated with" exact="pneumonia" post="(Morens, Taubenberger and Fauci 2008; Metersky etÂ al. 2012;"/>
  <result pre="al. 2012; Yin and WunderinkÂ 2018; Al-Baadani etÂ al. 2019)." exact="Primary" post="viral pneumonias are often complicated by bacterial co-infection as"/>
  <result pre="2012; Yin and WunderinkÂ 2018; Al-Baadani etÂ al. 2019). Primary" exact="viral" post="pneumonias are often complicated by bacterial co-infection as they"/>
  <result pre="etÂ al. 2019). Primary viral pneumonias are often complicated by" exact="bacterial" post="co-infection as they transform to viral-bacterial and bacterial pneumonias"/>
  <result pre="complicated by bacterial co-infection as they transform to viral-bacterial and" exact="bacterial" post="pneumonias (Oswald, Shooter and Curwen 1958; Bisno etÂ al."/>
  <result pre="expert circles: â€˜The influenza awards a sentence, and it is" exact="bacterial" post="flora that carries it outâ€™ (Cruveilhier 1919). The clinical"/>
  <result pre="carries it outâ€™ (Cruveilhier 1919). The clinical picture of severe" exact="viral" post="respiratory infections often presents with symptoms of primary viral"/>
  <result pre="it outâ€™ (Cruveilhier 1919). The clinical picture of severe viral" exact="respiratory" post="infections often presents with symptoms of primary viral pneumonia."/>
  <result pre="outâ€™ (Cruveilhier 1919). The clinical picture of severe viral respiratory" exact="infections" post="often presents with symptoms of primary viral pneumonia. The"/>
  <result pre="of severe viral respiratory infections often presents with symptoms of" exact="primary" post="viral pneumonia. The development of primary viral pneumonia in"/>
  <result pre="severe viral respiratory infections often presents with symptoms of primary" exact="viral pneumonia." post="The development of primary viral pneumonia in case of"/>
  <result pre="presents with symptoms of primary viral pneumonia. The development of" exact="primary" post="viral pneumonia in case of a viral respiratory infection"/>
  <result pre="with symptoms of primary viral pneumonia. The development of primary" exact="viral pneumonia" post="in case of a viral respiratory infection is probably"/>
  <result pre="symptoms of primary viral pneumonia. The development of primary viral" exact="pneumonia" post="in case of a viral respiratory infection is probably"/>
  <result pre="The development of primary viral pneumonia in case of a" exact="viral" post="respiratory infection is probably related to co-expression of glycoproteins"/>
  <result pre="development of primary viral pneumonia in case of a viral" exact="respiratory" post="infection is probably related to co-expression of glycoproteins and"/>
  <result pre="of primary viral pneumonia in case of a viral respiratory" exact="infection" post="is probably related to co-expression of glycoproteins and glycolipids"/>
  <result pre="with terminal Î±2,3-linked sialic acid (which plays the role of" exact="respiratory" post="virus receptor), and to the transmembrane serine protease TMPRSS2"/>
  <result pre="protease TMPRSS2 (which itself plays a role in proteolytically activating" exact="viral" post="HA and S protein) of the epithelial cells of"/>
  <result pre="in proteolytically activating viral HA and S protein) of the" exact="epithelial" post="cells of alveoli and bronchioles (Ibricevic etÂ al. 2006;"/>
  <result pre="etÂ al. 2019; Tortorici etÂ al. 2019). The vulnerability to" exact="bacterial" post="co-infection during respiratory viral pandemics is associated with multiple"/>
  <result pre="Tortorici etÂ al. 2019). The vulnerability to bacterial co-infection during" exact="respiratory" post="viral pandemics is associated with multiple factors: virus-induced dysbiosis"/>
  <result pre="etÂ al. 2019). The vulnerability to bacterial co-infection during respiratory" exact="viral" post="pandemics is associated with multiple factors: virus-induced dysbiosis and"/>
  <result pre="factors: virus-induced dysbiosis and disruption of barrier function of the" exact="epithelial" post="lining of respiratory airways (Pittet etÂ al. 2010; Ellis"/>
  <result pre="and disruption of barrier function of the epithelial lining of" exact="respiratory" post="airways (Pittet etÂ al. 2010; Ellis etÂ al. 2015;"/>
  <result pre="etÂ al. 2016; Brand etÂ al. 2018). Pneumonias associated with" exact="respiratory" post="viral infections are an independent factor in disease severity"/>
  <result pre="al. 2016; Brand etÂ al. 2018). Pneumonias associated with respiratory" exact="viral" post="infections are an independent factor in disease severity and"/>
  <result pre="2016; Brand etÂ al. 2018). Pneumonias associated with respiratory viral" exact="infections" post="are an independent factor in disease severity and mortality"/>
  <result pre="associated with respiratory viral infections are an independent factor in" exact="disease" post="severity and mortality (Maruyama etÂ al. 2016; IshiguroÂ etÂ"/>
  <result pre="al. 2017). This means that the main problem of severe" exact="viral" post="infections, in the past as well as in the"/>
  <result pre="the present, has been the problem of viral, viral-bacterial and" exact="secondary" post="bacterial pneumonias. ANTIVIRAL THERAPY The biology of influenza viruses"/>
  <result pre="present, has been the problem of viral, viral-bacterial and secondary" exact="bacterial" post="pneumonias. ANTIVIRAL THERAPY The biology of influenza viruses and"/>
  <result pre="variability and antigenic properties. This means that pandemics of new" exact="respiratory" post="infections will always start in the absence of immune"/>
  <result pre="and antigenic properties. This means that pandemics of new respiratory" exact="infections" post="will always start in the absence of immune prophylactics"/>
  <result pre="pandemics of new respiratory infections will always start in the" exact="absence of" post="immune prophylactics and treatments. This underlines the necessity of"/>
  <result pre="and development of treatments for the prevention and treatment of" exact="respiratory" post="viral infections and in particular for coronaviruses and influenza"/>
  <result pre="development of treatments for the prevention and treatment of respiratory" exact="viral" post="infections and in particular for coronaviruses and influenza A"/>
  <result pre="of treatments for the prevention and treatment of respiratory viral" exact="infections" post="and in particular for coronaviruses and influenza A viruses."/>
  <result pre="et al. 2020 The nature of RNA viruses suggests that" exact="systemic" post="interferon alfa-2b might be effective as non-specific background therapy,"/>
  <result pre="they may be considered in case of local symptoms (rhinitis," exact="pharyngitis" post="etc.). Usage of systemic interferon inducers such as tilorone"/>
  <result pre="in case of local symptoms (rhinitis, pharyngitis etc.). Usage of" exact="systemic" post="interferon inducers such as tilorone and cycloferon (Ekins et"/>
  <result pre="et al. 2020; Ekins and Madrid 2020) may result in" exact="secondary" post="immunosuppression 10â€&quot;14 days later, which can lead to another"/>
  <result pre="therapy also includes targeted agents that affect enzymes of the" exact="viral" post="genome replication; this includes oseltamivir, and the most potent"/>
  <result pre="influenza A and B viruses. The current knowledge of the" exact="viral" post="nature and pathogenetic properties of the infectious process allows"/>
  <result pre="knowledge of the viral nature and pathogenetic properties of the" exact="infectious" post="process allows us to consider the possibility of using"/>
  <result pre="of internalization of coronaviruses and influenza A viruses into the" exact="epithelial" post="cells (Simmons 2013; Garten etÂ al. 2015). The activity"/>
  <result pre="etÂ al. 2015). The activity of trypsin-like proteinases in the" exact="upper" post="respiratory tract significantly depends on the activity of inhibitors"/>
  <result pre="al. 2015). The activity of trypsin-like proteinases in the upper" exact="respiratory" post="tract significantly depends on the activity of inhibitors of"/>
  <result pre="the activity of inhibitors of secretory leucoproteinases and in the" exact="lower" post="respiratory tract it depends on the surfactant (Kido etÂ"/>
  <result pre="activity of inhibitors of secretory leucoproteinases and in the lower" exact="respiratory" post="tract it depends on the surfactant (Kido etÂ al."/>
  <result pre="and Kvetina 2004); and the ability to locally (in the" exact="respiratory" post="airways) stimulate the secretion of IgA and IgG (Yang"/>
  <result pre="in a list of medications used for the treatment of" exact="viral" post="pneumonias. An important role in the pathogenesis of respiratory"/>
  <result pre="of viral pneumonias. An important role in the pathogenesis of" exact="respiratory" post="infections is being played by the virus-induced oxidative stress"/>
  <result pre="viral pneumonias. An important role in the pathogenesis of respiratory" exact="infections" post="is being played by the virus-induced oxidative stress (Schwarz"/>
  <result pre="symptoms and complications of virus-associated pneumonias. Xanthine oxidoreductase is a" exact="cytosolic" post="enzyme of purine catabolism (Frederiks and Vreeling-Sindelarova 2002; Agarwal,"/>
  <result pre="and Kelley 2013), i.e. it can recycle this vasodilating agent." exact="Local" post="production of the prooxidative complex (O2â€&quot;â€¢, H2O2, NOâ€¢, ONOOâ€&quot;)"/>
  <result pre="H2O2, NOâ€¢, ONOOâ€&quot;) is potentially very dangerous, especially in the" exact="vascular" post="bed of the lungs. Nevertheless, the attempts of using"/>
  <result pre="and Struthers 2009), for the treatment of influenza A virus-induced" exact="pneumonia" post="in daily doses of 5â€&quot;50Â mg/kg have failed. Allopurinol"/>
  <result pre="shown any effects on the evolution and outcomes of the" exact="viral infection" post="(Dolganova and Sharonov 1997). Lack of therapeutic effect in"/>
  <result pre="any effects on the evolution and outcomes of the viral" exact="infection" post="(Dolganova and Sharonov 1997). Lack of therapeutic effect in"/>
  <result pre="xanthine oxidoreductase, administration of heparin seems feasible as prophylaxis of" exact="pulmonary embolism" post="with the objective of the desorption of xanthine oxidoreductase"/>
  <result pre="source of the active forms and metabolites of oxygen during" exact="respiratory" post="viral infections is mitochondria (To etÂ al. 2020). Melatonin"/>
  <result pre="of the active forms and metabolites of oxygen during respiratory" exact="viral" post="infections is mitochondria (To etÂ al. 2020). Melatonin is"/>
  <result pre="the active forms and metabolites of oxygen during respiratory viral" exact="infections" post="is mitochondria (To etÂ al. 2020). Melatonin is a"/>
  <result pre="has noticeable positive effects on the evolution and outcomes of" exact="viral" post="infections under experimental conditions (Srinivasan, Mohamed and Kato 2012;"/>
  <result pre="noticeable positive effects on the evolution and outcomes of viral" exact="infections" post="under experimental conditions (Srinivasan, Mohamed and Kato 2012; Silvestri"/>
  <result pre="superoxide radical is produced in the area of inflammation during" exact="viral" post="pneumonias. This may occur via reduction of ferric ions"/>
  <result pre="of a body is a life/death issue in case of" exact="viral" post="pneumonias. There were earlier attempts to use available complexones"/>
  <result pre="available complexones (for example, deferoxamine) to bind ferric ions during" exact="viral pneumonia;" post="contrary to the expected, not only did they show"/>
  <result pre="effective use as a supportive agent in the treatment of" exact="pneumonia" post="(Ilyashenko etÂ al. 2001; Luzhnikov etÂ al. 2006) and"/>
  <result pre="pneumonia (Ilyashenko etÂ al. 2001; Luzhnikov etÂ al. 2006) and" exact="viral" post="infections (Pavelkina, Yerovichenkov and Pak 2010). In clinical practice,"/>
  <result pre="(Ilyashenko etÂ al. 2001; Luzhnikov etÂ al. 2006) and viral" exact="infections" post="(Pavelkina, Yerovichenkov and Pak 2010). In clinical practice, chloroquine"/>
  <result pre="and sulfate for the following indications: treatment and prevention of" exact="malaria" post="(Mengesha and Makonnen 1999; Bello, Chika and Bello 2010;"/>
  <result pre="and Bello 2010; Waqar, Khushdil and Haque 2016); treatment of" exact="leprosy" post="(MeinÃ£o etÂ al. 1996; Bezerra etÂ al. 2005; Gordon"/>
  <result pre="etÂ al. 2018); as an anti-inflammatory agent in patients with" exact="rheumatoid arthritis" post="(Augustijns etÂ al. 1992; Schrezenmeier and Dorner 2020); treatment"/>
  <result pre="al. 2018); as an anti-inflammatory agent in patients with rheumatoid" exact="arthritis" post="(Augustijns etÂ al. 1992; Schrezenmeier and Dorner 2020); treatment"/>
  <result pre="(Augustijns etÂ al. 1992; Schrezenmeier and Dorner 2020); treatment of" exact="antiphospholipid syndrome" post="(Tektonidou etÂ al. 2019); treatment of Sjogren's syndrome (Vivino"/>
  <result pre="etÂ al. 1992; Schrezenmeier and Dorner 2020); treatment of antiphospholipid" exact="syndrome" post="(Tektonidou etÂ al. 2019); treatment of Sjogren's syndrome (Vivino"/>
  <result pre="treatment of antiphospholipid syndrome (Tektonidou etÂ al. 2019); treatment of" exact="Sjogren's syndrome" post="(Vivino etÂ al. 2016; Shivakumar etÂ al. 2018; LeeÂ"/>
  <result pre="of antiphospholipid syndrome (Tektonidou etÂ al. 2019); treatment of Sjogren's" exact="syndrome" post="(Vivino etÂ al. 2016; Shivakumar etÂ al. 2018; LeeÂ"/>
  <result pre="etÂ al. 2018; LeeÂ etÂ al. 2019); treatment of amoebic" exact="hepatitis" post="and hepatic abscesses (Sodeman etÂ al. 1951; Cohen and"/>
  <result pre="hepatic abscesses (Sodeman etÂ al. 1951; Cohen and Reynolds 1975);" exact="cancer" post="treatment as sensitizing agent (Solomon and Lee 2009; Maycotte"/>
  <result pre="etÂ al. 2012; Kimura etÂ al. 2013); and treatment of" exact="metabolic syndrome" post="(Kastan, Semenkovich and Schneider 2008; McGill etÂ al. 2019)"/>
  <result pre="al. 2012; Kimura etÂ al. 2013); and treatment of metabolic" exact="syndrome" post="(Kastan, Semenkovich and Schneider 2008; McGill etÂ al. 2019)"/>
  <result pre="Schneider 2008; McGill etÂ al. 2019) and inflammatory diseases of" exact="bacterial" post="nature (in synergy with antibiotics (Crowle and May 1990;"/>
  <result pre="(Shibata etÂ al. 1983), which results in the inhibition of" exact="viral" post="replication (Ooi etÂ al. 2006; Di Trani etÂ al."/>
  <result pre="of chloroquine to inhibit the acidification of endosomes that contain" exact="respiratory" post="viruses, and thus to block the release of their"/>
  <result pre="in the cisternae of Golgi apparatus with the support of" exact="secondary" post="protein matrices that form functional heterogenic associations (conveyor lines)"/>
  <result pre="As all participants of the interaction between human cells and" exact="respiratory" post="RNA viruses (glycoproteins and glycolipids) are richly decorated by"/>
  <result pre="glycans with terminal sialic acids, which are recognized by the" exact="viral" post="particles as specific receptors, the chloroquine-induced disruption of the"/>
  <result pre="chloroquine-induced disruption of the processes of sialylation/glycosylation of cellular and" exact="viral" post="participants of this interaction is reflected in its antiviral"/>
  <result pre="reflected in its antiviral effects. The participation of glycans in" exact="viral" post="adhesion and proliferation are extremely important. A wide array"/>
  <result pre="opens new opportunities for the inhibition of the process of" exact="viral" post="transmission, for example, by using them to prevent infection"/>
  <result pre="of viral transmission, for example, by using them to prevent" exact="infection" post="by herpes simplex virus type I. A method of"/>
  <result pre="transmission, for example, by using them to prevent infection by" exact="herpes" post="simplex virus type I. A method of prevention and"/>
  <result pre="by using them to prevent infection by herpes simplex virus" exact="type I." post="A method of prevention and treatment of aspiration pneumonias"/>
  <result pre="A proposed dose of DMSO (0.3â€&quot;0.4Â ml) does not affect" exact="morphology" post="or functional properties of blood cells (Gurtovenko and Anwar"/>
  <result pre="be used at concentrations similar to their original indication. CONCLUSIONS" exact="Respiratory" post="RNA viruses are anthropozoonotic infectious pathogens that have natural"/>
  <result pre="to their original indication. CONCLUSIONS Respiratory RNA viruses are anthropozoonotic" exact="infectious" post="pathogens that have natural reservoirs and form dynamic genetic"/>
  <result pre="interchange or spillover of genetic material between the genomes of" exact="familial" post="RNA viruses of humans and animals. This inevitably leads"/>
  <result pre="properties of these strains. This means that epidemics of new" exact="respiratory" post="RNA viral infections will always begin in the absence"/>
  <result pre="these strains. This means that epidemics of new respiratory RNA" exact="viral" post="infections will always begin in the absence of medications"/>
  <result pre="strains. This means that epidemics of new respiratory RNA viral" exact="infections" post="will always begin in the absence of medications for"/>
  <result pre="new respiratory RNA viral infections will always begin in the" exact="absence of" post="medications for their immune-mediated prevention or treatment. This underlines"/>
  <result pre="therapeutic drugs that could be used in the treatment of" exact="respiratory" post="RNA viral infections. This review has focused on the"/>
  <result pre="that could be used in the treatment of respiratory RNA" exact="viral" post="infections. This review has focused on the past and"/>
  <result pre="Clearly, our future will be very much defined by such" exact="viral" post="outbreaks if we are not able to identify broad-spectrum"/>
  <result pre="therapeutics. The reliance on a single magic bullet for every" exact="disease" post="may be unrealistic and we therefore need to consider"/>
  <result pre="of such molecules may be detrimental, short-term use may prevent" exact="viral" post="entry and protect the individual. There is certainly much"/>
  <result pre="be performed to understand how combinations of drugs for these" exact="respiratory" post="viruses may work together. While interest in antiviral research"/>
  <result pre="AgarwalA, BanerjeeA, BanerjeeUCXanthine oxidoreductase: a journey from purine metabolism to" exact="cardiovascular" post="excitationâ€&quot;contraction coupling. Crit Rev Biotechnol. 2011;31:264â€&quot;80.21774633 AhnH, KimJ, JeungEBet"/>
  <result pre="al.Dependence on O2-generation by xanthine oxidase of pathogenesis of influenza" exact="virus infection" post="in mice. J Clin Invest. 1990;85:739â€&quot;45.2155924 AkhmedovVA, BudylginAV, DolgikhVTThe"/>
  <result pre="on O2-generation by xanthine oxidase of pathogenesis of influenza virus" exact="infection" post="in mice. J Clin Invest. 1990;85:739â€&quot;45.2155924 AkhmedovVA, BudylginAV, DolgikhVTThe"/>
  <result pre="matrix metalloproteinase 9 (MMP-9) and TIMP-1 activities in patients with" exact="chronic" post="and recurrent pancreatitis. Eksp Klin Gastroenterol. 2010;6:11â€&quot;3. Al-BaadaniAM, ElzeinFE,"/>
  <result pre="9 (MMP-9) and TIMP-1 activities in patients with chronic and" exact="recurrent" post="pancreatitis. Eksp Klin Gastroenterol. 2010;6:11â€&quot;3. Al-BaadaniAM, ElzeinFE, AlhemyadiSAet al.Characteristics"/>
  <result pre="Klin Gastroenterol. 2010;6:11â€&quot;3. Al-BaadaniAM, ElzeinFE, AlhemyadiSAet al.Characteristics and outcome of" exact="viral pneumonia" post="caused by influenza and Middle East respiratory syndrome-coronavirus infections:"/>
  <result pre="Gastroenterol. 2010;6:11â€&quot;3. Al-BaadaniAM, ElzeinFE, AlhemyadiSAet al.Characteristics and outcome of viral" exact="pneumonia" post="caused by influenza and Middle East respiratory syndrome-coronavirus infections:"/>
  <result pre="outcome of viral pneumonia caused by influenza and Middle East" exact="respiratory" post="syndrome-coronavirus infections: a 4-year experience from a tertiary care"/>
  <result pre="analogs as a promising strategy for the treatment of emerging" exact="viral" post="diseases. Pharmacol Res Perspect. 2017;5:e00293.28596841 Al-MuharrmiZUnderstanding the influenza AH1N1"/>
  <result pre="J. 2010;10:187â€&quot;95.21509228 AndrusishinaIN, VazhnichayaEM, DonchenkoEAet al.Agent for the treatment of" exact="iron overload" post="and hemochromatosis. Russian Federation patent RU 2557959C12014. AskwithCC, deÂ"/>
  <result pre="DonchenkoEAet al.Agent for the treatment of iron overload and hemochromatosis." exact="Russian" post="Federation patent RU 2557959C12014. AskwithCC, deÂ SilvaD, KaplanJMolecular biology"/>
  <result pre="Mol Microbiol. 1996;20:27â€&quot;34.8861201 AugustijnsP, GeusensP, VerbekeNChloroquine levels in blood during" exact="chronic" post="treatment of patients with rheumatoid arthritis. Eur J Clin"/>
  <result pre="VerbekeNChloroquine levels in blood during chronic treatment of patients with" exact="rheumatoid arthritis." post="Eur J Clin Pharmacol. 1992;42:429â€&quot;33.1307690 BakerNC, EkinsS, WilliamsAJet al.A"/>
  <result pre="better than artemisinin combination therapy as first line treatment in" exact="adult" post="Nigerians with uncomplicated malaria? A cost effectiveness analysis. Afr"/>
  <result pre="MaorG, FilocamoMet al.Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase." exact="Blood" post="Cells Mol Dis. 2013;50:141â€&quot;5.23158495 BertramS, GlowackaI, BlazejewskaPet al.TMPRSS2 and"/>
  <result pre="clinical trial of clofazimine compared with chloroquine in patients with" exact="systemic" post="lupus erythematosus. Arthritis Rheum. 2005;52:3073â€&quot;8.16200586 BhattacharyyaD, SenPCThe effect of"/>
  <result pre="trial of clofazimine compared with chloroquine in patients with systemic" exact="lupus erythematosus." post="Arthritis Rheum. 2005;52:3073â€&quot;8.16200586 BhattacharyyaD, SenPCThe effect of binding of"/>
  <result pre="clofazimine compared with chloroquine in patients with systemic lupus erythematosus." exact="Arthritis" post="Rheum. 2005;52:3073â€&quot;8.16200586 BhattacharyyaD, SenPCThe effect of binding of chlorpromazine"/>
  <result pre="core complex. J Virol. 2003;77:8801â€&quot;11.12885899 BoueizA, DamarlaM, HassounPMXanthine oxidoreductase in" exact="respiratory" post="and cardiovascular disorder. Am J Physiol Lung Cell Mol"/>
  <result pre="J Virol. 2003;77:8801â€&quot;11.12885899 BoueizA, DamarlaM, HassounPMXanthine oxidoreductase in respiratory and" exact="cardiovascular" post="disorder. Am J Physiol Lung Cell Mol Physiol. 2008;294:L830â€&quot;40.18344415"/>
  <result pre="endotoxemia. Hypertension. 1999;33:1243â€&quot;9.10334819 BrandJD, LazrakA, TrombleyJEet al.Influenza-mediated reduction of lung" exact="epithelial" post="ion channel activity leads to dysregulated pulmonary fluid homeostasis."/>
  <result pre="reduction of lung epithelial ion channel activity leads to dysregulated" exact="pulmonary" post="fluid homeostasis. JCI Insight. 2018;3:123467.30333319 BroxmeyerLBird flu, influenza and"/>
  <result pre="2018;3:123467.30333319 BroxmeyerLBird flu, influenza and 1918: the case for mutant" exact="Avian" post="tuberculosis. Med Hypotheses. 2006;67:1006â€&quot;15.16806732 BullenJJ, WardCG, RogersHJThe critical role"/>
  <result pre="Mol Sci. 2017;18:E1541.28714909 BÃ¡rcenaM, OostergetelGT, BartelinkWet al.Cryo-electron tomography of mouse" exact="hepatitis" post="virus: insights into the structure of the coronavirion. Proc"/>
  <result pre="al.The time course of the immune response to experimental coronavirus" exact="infection" post="of man. Epidemiol Infect. 1990;105:435â€&quot;46.2170159 CalyL, DruceJD, CattonMGet al.The"/>
  <result pre="WangD, XuFet al.Activation of IL-27 signaling promotes development of postinfluenza" exact="pneumococcal pneumonia." post="EMBO Mol Med. 2014;6:120â€&quot;40.24408967 CarlsonCM, TurpinEA, MoserLAet al.Transforming growth"/>
  <result pre="pathogenic H5N1 influenza pathogenesis. PLoS Pathog. 2010;6:e1001136.20949074 CassatJE, SkaarEPIron in" exact="infection" post="and immunity. Cell Host Microbe. 2013;13:509â€&quot;19.23684303 CataldiM, SblendorioV, LeoAet"/>
  <result pre="the interaction of adenoviruses with Hela cells. I. Penetration of" exact="type 5" post="and intracellular release of the DNA genome. Virology. 1970;40:462â€&quot;77.5437781"/>
  <result pre="AhnJHet al.Pretreated quercetin protects gerbil hippocampal CA1 pyramidal neurons from" exact="transient" post="cerebral ischemic injury by increasing the expression of antioxidant"/>
  <result pre="al.Pretreated quercetin protects gerbil hippocampal CA1 pyramidal neurons from transient" exact="cerebral" post="ischemic injury by increasing the expression of antioxidant enzymes."/>
  <result pre="Antiviral Res. 2020;178:104786.32251767 CillÃ³nizC, EwigS, MenÃ©ndezRet al.Bacterial co-infection with H1N1" exact="infection" post="in patients admitted with community acquired pneumonia. J Infect."/>
  <result pre="al.Bacterial co-infection with H1N1 infection in patients admitted with community" exact="acquired" post="pneumonia. J Infect. 2012;65:223â€&quot;30.22543245 CohenHG, ReynoldsTBComparison of metronidazole and"/>
  <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother."/>
  <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014;58:4875â€&quot;84.24841269"/>
  <result pre="associated with divergent inhibitory effects of chloroquine on human and" exact="avian influenza" post="A viruses. Virol J. 2007;4:39.17477867 DoelJJ, GodbergBL, EisenthalRet al.Reduction"/>
  <result pre="2015;21:368â€&quot;71.25628038 DuganVG, ChenR, SpiroDJet al.The evolutionary genetics and emergence of" exact="avian influenza" post="viruses in wild birds. PLoS Pathog. 2008;4:e1000076.18516303 DulchavskySA, DavidsonSB,"/>
  <result pre="represses inflammatory cytokine production from human blood cells and reduces" exact="autoimmune" post="arthritis. PLoS One. 2016;11:e0152538.27031833 EllisGT, DavidsonS, CrottaSet al.TRAIL+ monocytes"/>
  <result pre="monocytes and monocyte-related cells cause lung damage and thereby increase" exact="susceptibility to" post="influenza-Streptococcus pneumoniae coinfection. EMBO Rep. 2015;16:1203â€&quot;18.26265006 FehrAR, PerlmanSCoronaviruses: an"/>
  <result pre="combination of chloroquine and micocycline, a therapeutic option in cerebrospinal" exact="infection" post="of Whipple`s disease refractory to treatment with ceftriaxone, meropenem"/>
  <result pre="and micocycline, a therapeutic option in cerebrospinal infection of Whipple`s" exact="disease" post="refractory to treatment with ceftriaxone, meropenem and co-trimoxazole. J"/>
  <result pre="ArantesJMet al.Increase of reactive oxygen species by desferrioxamine during experimental" exact="Chagas' disease." post="Redox Rep. 2010;15:185â€&quot;90.20663295 FrancisTA new type of virus from"/>
  <result pre="of urate, xanthine oxidase and the effects of allopurinol in" exact="vascular" post="oxidative stress. Vasc Health Risk Manag. 2009;5:265â€&quot;72.19436671 GholampourF, SakiNHepatic"/>
  <result pre="Biophys. 2019;38:27â€&quot;38.30657458 GhoneimHE, ThomasPG, McCullersJADepletion of alveolar macrophages during influenza" exact="infection" post="facilitates bacterial superinfection. J Immunol. 2013;191:1250â€&quot;9.23804714 GibbsBF, SchmutzlerW, VollrathIBet"/>
  <result pre="GhoneimHE, ThomasPG, McCullersJADepletion of alveolar macrophages during influenza infection facilitates" exact="bacterial" post="superinfection. J Immunol. 2013;191:1250â€&quot;9.23804714 GibbsBF, SchmutzlerW, VollrathIBet al.Ambroxol inhibits"/>
  <result pre="ElySFet al.Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1" exact="viral" post="infections. Arch Pathol Lab Med. 2010;134:235â€&quot;43.20121613 GiovanellaF, FerreiraGK, deÂ"/>
  <result pre="al.The British Society for Rheumatology guideline for the management of" exact="systemic" post="lupus erythematosus in adults. Rheumatology (Oxford). 2018;57:e1â€&quot;45.29029350 GriffithsEIron and"/>
  <result pre="British Society for Rheumatology guideline for the management of systemic" exact="lupus erythematosus" post="in adults. Rheumatology (Oxford). 2018;57:e1â€&quot;45.29029350 GriffithsEIron and bacterial virulence"/>
  <result pre="systemic lupus erythematosus in adults. Rheumatology (Oxford). 2018;57:e1â€&quot;45.29029350 GriffithsEIron and" exact="bacterial" post="virulence â€&quot; a brief overview. Biol Met. 1991;4:7â€&quot;13.1830211 GuptaPRAmbroxol"/>
  <result pre="resurgence of an old molecule as an anti-inflammatory agent in" exact="chronic" post="obstructive airway diseases. Lung India. 2010;27:46â€&quot;8.20616932 GurtovenkoAA, AnwarJModulating the"/>
  <result pre="USA. 1989;86:10108â€&quot;12.2481311 HamreD, ProcknowJJA new virus isolated from the human" exact="respiratory" post="tract. Proc Soc Exp Biol Med. 1966;121:190â€&quot;3.4285768 HanadaS, PirzadehM,"/>
  <result pre="Proc Soc Exp Biol Med. 1966;121:190â€&quot;3.4285768 HanadaS, PirzadehM, CarverKYet al.Respiratory" exact="viral" post="infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol."/>
  <result pre="1966;121:190â€&quot;3.4285768 HanadaS, PirzadehM, CarverKYet al.Respiratory viral infection-induced microbiome alterations and" exact="secondary" post="bacterial pneumonia. Front Immunol. 2018;9:2640.30505304 HarrisCM, MasseyVThe reaction of"/>
  <result pre="HanadaS, PirzadehM, CarverKYet al.Respiratory viral infection-induced microbiome alterations and secondary" exact="bacterial pneumonia." post="Front Immunol. 2018;9:2640.30505304 HarrisCM, MasseyVThe reaction of reduced xanthine"/>
  <result pre="O-glycosylation pathways involves pH-dependent complex formation that is impaired in" exact="cancer" post="cells. J Biol Chem. 2011;286:38329â€&quot;40.21911486 HauseBM, DucatezM, CollinEAet al.Isolation"/>
  <result pre="Biol Chem. 2011;286:38329â€&quot;40.21911486 HauseBM, DucatezM, CollinEAet al.Isolation of a novel" exact="swine influenza" post="virus from Oklahoma in 2011 which is distantly related"/>
  <result pre="only proteolysis by TMPRSS2 augments entry driven by the severe" exact="acute" post="respiratory syndrome coronavirus spike protein. J Virol. 2014;88:1293â€&quot;307.24227843 HollidayLSVacuolar"/>
  <result pre="proteolysis by TMPRSS2 augments entry driven by the severe acute" exact="respiratory" post="syndrome coronavirus spike protein. J Virol. 2014;88:1293â€&quot;307.24227843 HollidayLSVacuolar H-ATPases"/>
  <result pre="by TMPRSS2 augments entry driven by the severe acute respiratory" exact="syndrome" post="coronavirus spike protein. J Virol. 2014;88:1293â€&quot;307.24227843 HollidayLSVacuolar H-ATPases (V-ATPases)"/>
  <result pre="receptor specificity and cell tropism in mouse and human airway" exact="epithelial" post="cells. J Virol. 2006;80:7469â€&quot;80.16840327 IlyashenkoKK, LuzhnikovEA, AbakumovMMet al.Sklifosovsky Research"/>
  <result pre="IlyashenkoKK, LuzhnikovEA, AbakumovMMet al.Sklifosovsky Research Institute for Emergency Medicine, assignees." exact="Russian" post="Federation patent RU 2205641C22001. IshiguroT, KagiyamaN, UozumiRet al.Clinical characteristics"/>
  <result pre="patent RU 2205641C22001. IshiguroT, KagiyamaN, UozumiRet al.Clinical characteristics of influenza-associated" exact="pneumonia" post="of adults: clinical features and factors contributing to severity"/>
  <result pre="Cell Biol. 1989;109:2721â€&quot;9.2556405 KastanMB, SemenkovichCF, SchneiderJUse of chloroquine to treat" exact="metabolic syndrome." post="United States patent US 20080319010A12008. KearneyJChloroquine as a potential"/>
  <result pre="Schmerz. 2015;29:89â€&quot;96. KeyaertsE, VijgenL, MaesPet al.In vitro inhibition of severe" exact="acute" post="respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun."/>
  <result pre="2015;29:89â€&quot;96. KeyaertsE, VijgenL, MaesPet al.In vitro inhibition of severe acute" exact="respiratory" post="syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323:264â€&quot;8.15351731"/>
  <result pre="KeyaertsE, VijgenL, MaesPet al.In vitro inhibition of severe acute respiratory" exact="syndrome" post="coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323:264â€&quot;8.15351731 KhomichOA,"/>
  <result pre="Biophys Res Commun. 2004;323:264â€&quot;8.15351731 KhomichOA, KochetkovSN, BartoschBet al.Redox biology of" exact="respiratory" post="viral infections. Viruses. 2018;10:E392.30049972 KidoH, OkumuraY, TakahashiEet al.Host envelope"/>
  <result pre="Res Commun. 2004;323:264â€&quot;8.15351731 KhomichOA, KochetkovSN, BartoschBet al.Redox biology of respiratory" exact="viral" post="infections. Viruses. 2018;10:E392.30049972 KidoH, OkumuraY, TakahashiEet al.Host envelope glycoprotein"/>
  <result pre="for entry into human cells by seasonal and highly pathogenic" exact="avian influenza" post="viruses. J Mol Genet Med. 2008;3:167â€&quot;75.19565019 KidoH, OkumuraY, YamadaHet"/>
  <result pre="Genet Med. 2008;3:167â€&quot;75.19565019 KidoH, OkumuraY, YamadaHet al.Secretory leukoprotease inhibitor and" exact="pulmonary" post="surfactant serve as principal defenses against influenza A virus"/>
  <result pre="and pulmonary surfactant serve as principal defenses against influenza A" exact="virus infection" post="in the airway and chemical agents up-regulating their levels"/>
  <result pre="pulmonary surfactant serve as principal defenses against influenza A virus" exact="infection" post="in the airway and chemical agents up-regulating their levels"/>
  <result pre="among influenza reservoirs. Viruses. 2018;10:E183.29642453 KimuraT, TakabatakeY, TakahashiAet al.Chloroquine in" exact="cancer" post="therapy: a double-edged sword of autophagy. Cancer Res. 2013;73:3â€&quot;7.23288916"/>
  <result pre="TakahashiAet al.Chloroquine in cancer therapy: a double-edged sword of autophagy." exact="Cancer" post="Res. 2013;73:3â€&quot;7.23288916 KingAMQ, LefkowitzEJ, MushegianARet al.Changes to taxonomy and"/>
  <result pre="NilssonP, LindÃ©nMet al.Detection of human coronavirus NL63, human metapneumovirus and" exact="respiratory" post="syncytial virus in children with respiratory tract infections in"/>
  <result pre="NL63, human metapneumovirus and respiratory syncytial virus in children with" exact="respiratory" post="tract infections in south-west Sweden. Clin Microbiol Infect. 2006;12:1089â€&quot;96.17002608"/>
  <result pre="metapneumovirus and respiratory syncytial virus in children with respiratory tract" exact="infections" post="in south-west Sweden. Clin Microbiol Infect. 2006;12:1089â€&quot;96.17002608 KosikI, YewdellJWInfluenza"/>
  <result pre="effect of chloroquine on the development of dry eye in" exact="Sjogren syndrome" post="animal model. Invest Ophthalmol Vis Sci. 2019;60:3708â€&quot;16.31479110 LeungHS, LiOT,"/>
  <result pre="of chloroquine on the development of dry eye in Sjogren" exact="syndrome" post="animal model. Invest Ophthalmol Vis Sci. 2019;60:3708â€&quot;16.31479110 LeungHS, LiOT,"/>
  <result pre="J Virol. 2012;86:10704â€&quot;13.22837202 LiF, WangW, HuLet al.Effect of ambroxol on" exact="pneumonia" post="caused by Pseudomonas aeruginosawith biofilm formation in an endotracheal"/>
  <result pre="is the major activating protease of influenza A virus in" exact="primary" post="human airway cells and influenza B virus in human"/>
  <result pre="primary human airway cells and influenza B virus in human" exact="type II" post="pneumocytes. J Virol. 2019;93:e00649â€&quot;19.31391268 LimYX, NgYL, TamJPet al.Human coronaviruses:"/>
  <result pre="review of virusâ€&quot;host interactions. Diseases. 2016;4:E26.28933406 LinCW, LinKH, HsiehTHet al.Severe" exact="acute" post="respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med"/>
  <result pre="of virusâ€&quot;host interactions. Diseases. 2016;4:E26.28933406 LinCW, LinKH, HsiehTHet al.Severe acute" exact="respiratory" post="syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med Microbiol."/>
  <result pre="virusâ€&quot;host interactions. Diseases. 2016;4:E26.28933406 LinCW, LinKH, HsiehTHet al.Severe acute respiratory" exact="syndrome" post="coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med Microbiol. 2006;46:375â€&quot;80.16553810"/>
  <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitro. Cell Discov. 2020;6:16.32194981 LiuM, ChenF, LiuTet al.The"/>
  <result pre="LiuM, ChenF, LiuTet al.The role of oxidative stress in influenza" exact="virus infection." post="Microbes Infect. 2017;19:580â€&quot;6.28918004 LiW, HulswitRJG, WidjajaIet al.Identification of sialic"/>
  <result pre="WidjajaIet al.Identification of sialic acid-binding function for the Middle East" exact="respiratory" post="syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci USA."/>
  <result pre="al.Identification of sialic acid-binding function for the Middle East respiratory" exact="syndrome" post="coronavirus spike glycoprotein. Proc Natl Acad Sci USA. 2017;114:E8508â€&quot;17.28923942"/>
  <result pre="PinchukTPet al.The use of â€˜Mexidolâ€™ in comprehensive treating patients with" exact="acute" post="exogenous poisoning. Bull Exp Biol Med. 2006;Supl. 1:190â€&quot;8. MakinoS,"/>
  <result pre="egress. Int J Mol Sci. 2017;18:E2649.29215568 MartÃ­n-LoechesI, Sanchez-CorralA, DiazEet al.Community-acquired" exact="respiratory" post="coinfection in critically ill patients with pandemic 2009 influenza"/>
  <result pre="Cell Biol. 1981;91:601â€&quot;13.7328111 MatsuyamaS, UjikeM, MorikawaSet al.Protease-mediated enhancement of severe" exact="acute" post="respiratory syndrome coronavirus infection. Proc Natl Acad Sci USA."/>
  <result pre="Biol. 1981;91:601â€&quot;13.7328111 MatsuyamaS, UjikeM, MorikawaSet al.Protease-mediated enhancement of severe acute" exact="respiratory" post="syndrome coronavirus infection. Proc Natl Acad Sci USA. 2005;102:12543â€&quot;7.16116101"/>
  <result pre="1981;91:601â€&quot;13.7328111 MatsuyamaS, UjikeM, MorikawaSet al.Protease-mediated enhancement of severe acute respiratory" exact="syndrome" post="coronavirus infection. Proc Natl Acad Sci USA. 2005;102:12543â€&quot;7.16116101 MaycotteP,"/>
  <result pre="Natl Acad Sci USA. 2005;102:12543â€&quot;7.16116101 MaycotteP, AryalS, CummingsCTet al.Chloroquine sensitizes" exact="breast cancer" post="cells to chemotherapy independent of autophagy. Autophagy. 2012;8:200â€&quot;12.22252008 McAuleyJL,"/>
  <result pre="Acad Sci USA. 2005;102:12543â€&quot;7.16116101 MaycotteP, AryalS, CummingsCTet al.Chloroquine sensitizes breast" exact="cancer" post="cells to chemotherapy independent of autophagy. Autophagy. 2012;8:200â€&quot;12.22252008 McAuleyJL,"/>
  <result pre="the 1918 influenza A virus PB1-F2 enhances the pathogenesis of" exact="viral" post="and secondary bacterial pneumonia. Cell Host Microbe. 2007;2:240â€&quot;9.18005742 McBrideR,"/>
  <result pre="influenza A virus PB1-F2 enhances the pathogenesis of viral and" exact="secondary" post="bacterial pneumonia. Cell Host Microbe. 2007;2:240â€&quot;9.18005742 McBrideR, vanÂ ZylM,"/>
  <result pre="A virus PB1-F2 enhances the pathogenesis of viral and secondary" exact="bacterial pneumonia." post="Cell Host Microbe. 2007;2:240â€&quot;9.18005742 McBrideR, vanÂ ZylM, FieldingBCThe coronavirus"/>
  <result pre="JohnsonM, HurstSet al.Low dose chloroquine decreases insulin resistance in human" exact="metabolic syndrome" post="but does not reduce carotid intima-media thickness. Diabetol Metab"/>
  <result pre="HurstSet al.Low dose chloroquine decreases insulin resistance in human metabolic" exact="syndrome" post="but does not reduce carotid intima-media thickness. Diabetol Metab"/>
  <result pre="Metab Syndr. 2019;11:61.31384309 McIntoshK, KapikianAZ, TurnerHCet al.Seroepidemiological studies of coronavirus" exact="infection" post="in adults and children. Am J Epidemiol. 1970;91:585â€&quot;92.4315625 McNameeLA,"/>
  <result pre="HarmsenAGBoth influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased" exact="susceptibility to" post="a secondary Streptococcus pneumoniae infection. Infect Immun. 2006;74:6707â€&quot;21.16982840 MeinÃ£oIM,"/>
  <result pre="dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a" exact="secondary" post="Streptococcus pneumoniae infection. Infect Immun. 2006;74:6707â€&quot;21.16982840 MeinÃ£oIM, SatoEI, AndradeLEet"/>
  <result pre="2006;74:6707â€&quot;21.16982840 MeinÃ£oIM, SatoEI, AndradeLEet al.Controlled trial with chloroquine diphosphate in" exact="systemic" post="lupus erythematosus. Lupus. 1996;5:237â€&quot;41.8803897 MengeshaT, MakonnenEComparative efficacy and safety"/>
  <result pre="MeinÃ£oIM, SatoEI, AndradeLEet al.Controlled trial with chloroquine diphosphate in systemic" exact="lupus erythematosus." post="Lupus. 1996;5:237â€&quot;41.8803897 MengeshaT, MakonnenEComparative efficacy and safety of chloroquine"/>
  <result pre="safety of chloroquine and alternative antimalarial drugs: a meta-analysis fromsix" exact="African" post="countries. East Afr Med J. 1999;76:314â€&quot;9.10750517 MeterskyML, MastertonRG, LodeHet"/>
  <result pre="1999;76:314â€&quot;9.10750517 MeterskyML, MastertonRG, LodeHet al.Epidemiology, microbiology, and treatment considerations for" exact="bacterial pneumonia" post="complicating influenza. Int J Infect Dis. 2012;16:e321â€&quot;31.22387143 MilewskaA, NowakP,"/>
  <result pre="MeterskyML, MastertonRG, LodeHet al.Epidemiology, microbiology, and treatment considerations for bacterial" exact="pneumonia" post="complicating influenza. Int J Infect Dis. 2012;16:e321â€&quot;31.22387143 MilewskaA, NowakP,"/>
  <result pre="A virus. J Virol. 2000;74:6015â€&quot;20.10846083 MorensDM, TaubenbergerJK, FauciASPredominant role of" exact="bacterial pneumonia" post="as a cause of death in pandemic influenza: implications"/>
  <result pre="virus. J Virol. 2000;74:6015â€&quot;20.10846083 MorensDM, TaubenbergerJK, FauciASPredominant role of bacterial" exact="pneumonia" post="as a cause of death in pandemic influenza: implications"/>
  <result pre="MulanguS, DoddLE, DaveyRTJr.et al.A randomized, controlled trial of Ebola virus" exact="disease" post="therapeutics. N Engl J Med. 2019;381:2293â€&quot;303.31774950 MuramotoY, NodaT, KawakamiEet"/>
  <result pre="NalB, ChanC, KienFet al.Differential maturation and subcellular localization of severe" exact="acute" post="respiratory syndrome coronavirus surface proteins S, M and E."/>
  <result pre="ChanC, KienFet al.Differential maturation and subcellular localization of severe acute" exact="respiratory" post="syndrome coronavirus surface proteins S, M and E. J"/>
  <result pre="KienFet al.Differential maturation and subcellular localization of severe acute respiratory" exact="syndrome" post="coronavirus surface proteins S, M and E. J Gen"/>
  <result pre="al.Ebolavirus is internalized into host cells via macropinocytosis in a" exact="viral" post="glycoprotein-dependent manner. PLoS Pathog. 2010;6:e1001121.20886108 NeumanBW, AdairBD, YoshiokaCet al.Supramolecular"/>
  <result pre="PLoS Pathog. 2010;6:e1001121.20886108 NeumanBW, AdairBD, YoshiokaCet al.Supramolecular architecture of severe" exact="acute" post="respiratory syndrome coronavirus revealed by electron cryomicroscopy. J Virol."/>
  <result pre="Pathog. 2010;6:e1001121.20886108 NeumanBW, AdairBD, YoshiokaCet al.Supramolecular architecture of severe acute" exact="respiratory" post="syndrome coronavirus revealed by electron cryomicroscopy. J Virol. 2006;80:7918â€&quot;28.16873249"/>
  <result pre="2010;6:e1001121.20886108 NeumanBW, AdairBD, YoshiokaCet al.Supramolecular architecture of severe acute respiratory" exact="syndrome" post="coronavirus revealed by electron cryomicroscopy. J Virol. 2006;80:7918â€&quot;28.16873249 NeumanBW,"/>
  <result pre="BMC Clin Pharmacol. 2002;2:8.12398791 Nita-LazarM, BanerjeeA, FengCet al.Desialylation of airway" exact="epithelial" post="cells during influenza virus infection enhances pneumococcal adhesion via"/>
  <result pre="Nita-LazarM, BanerjeeA, FengCet al.Desialylation of airway epithelial cells during influenza" exact="virus infection" post="enhances pneumococcal adhesion via galectins binding. Mol Immunol. 2015;65:1â€&quot;16.25597246"/>
  <result pre="BanerjeeA, FengCet al.Desialylation of airway epithelial cells during influenza virus" exact="infection" post="enhances pneumococcal adhesion via galectins binding. Mol Immunol. 2015;65:1â€&quot;16.25597246"/>
  <result pre="ambroxol. Free Radic Biol Med. 1994;16:517â€&quot;22.8005537 ObiAT, TignanelliCJ, JacobsBNet al.Empirical" exact="systemic" post="anticoagulation is associated with decreased venous thromboembolism in critically"/>
  <result pre="ObiAT, TignanelliCJ, JacobsBNet al.Empirical systemic anticoagulation is associated with decreased" exact="venous thromboembolism" post="in critically ill influenza A H1N1 acute respiratory distress"/>
  <result pre="with decreased venous thromboembolism in critically ill influenza A H1N1" exact="acute" post="respiratory distress syndrome patients. J Vasc Surg Venous Lymphat"/>
  <result pre="decreased venous thromboembolism in critically ill influenza A H1N1 acute" exact="respiratory" post="distress syndrome patients. J Vasc Surg Venous Lymphat Disord."/>
  <result pre="thromboembolism in critically ill influenza A H1N1 acute respiratory distress" exact="syndrome" post="patients. J Vasc Surg Venous Lymphat Disord. 2019;7:317â€&quot;24.30477976 OhkumaS,"/>
  <result pre="Rev. 2006;58:87â€&quot;114.16507884 PageS, PowellD, BenboubetraMet al.Xanthine oxidoreductase in human mammary" exact="epithelial" post="cells: activation in response to inflammatory cytokines. Biochim Biophys"/>
  <result pre="HINI pandemic influenza. PLoS One. 2009;4:e8540.20046873 PappasG, KiriazeIJ., FalagasMEInsights into" exact="infectious disease" post="in the era of Hippocrates. Int J Infect Dis."/>
  <result pre="pandemic influenza. PLoS One. 2009;4:e8540.20046873 PappasG, KiriazeIJ., FalagasMEInsights into infectious" exact="disease" post="in the era of Hippocrates. Int J Infect Dis."/>
  <result pre="J Infect Dis. 2008;12:347â€&quot;50.18178502 ParsonsL, BouwmanKM, AzurmendiHet al.Glycosylation of the" exact="viral" post="attachment protein of avian coronavirus is essential for host"/>
  <result pre="PavelkinaV, YerovichenkovA, PakSOptimization of pathogenetic therapy in the diseases of" exact="viral" post="and bacterial etiology. Farmateka. 2010;4:64â€&quot;71. PensaertMBPorcine epidemic diarrhea. :"/>
  <result pre="PakSOptimization of pathogenetic therapy in the diseases of viral and" exact="bacterial" post="etiology. Farmateka. 2010;4:64â€&quot;71. PensaertMBPorcine epidemic diarrhea. : StrawBE, D'AllaireS,"/>
  <result pre="2010;4:64â€&quot;71. PensaertMBPorcine epidemic diarrhea. : StrawBE, D'AllaireS, MengelingWLet al. (eds.)" exact="Diseases" post="of Swine, 8th ednAmes, Iowa: Iowa State University Press,"/>
  <result pre="has ion channel activity. Cell. 1992;69:517â€&quot;28.1374685 PittetLA, Hall-StoodleyL, RutkowskiMRet al.Influenza" exact="virus infection" post="decreases tracheal mucociliary velocity and clearance of Streptococcus pneumonia."/>
  <result pre="ion channel activity. Cell. 1992;69:517â€&quot;28.1374685 PittetLA, Hall-StoodleyL, RutkowskiMRet al.Influenza virus" exact="infection" post="decreases tracheal mucociliary velocity and clearance of Streptococcus pneumonia."/>
  <result pre="al.Influenza virus infection decreases tracheal mucociliary velocity and clearance of" exact="Streptococcus pneumonia." post="Am J Respir Cell Mol Biol. 2010;42:450â€&quot;60.19520922 PossWB, HuecksteadtTP,"/>
  <result pre="particle influenza vaccines. Expert Rev Vaccines. 2016;15:1281â€&quot;93.27058302 RamadanN, ShaibHMiddle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): a review. Germs. 2019;9:35â€&quot;42.31119115 ReavesB, BantingGVacuolar"/>
  <result pre="influenza vaccines. Expert Rev Vaccines. 2016;15:1281â€&quot;93.27058302 RamadanN, ShaibHMiddle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): a review. Germs. 2019;9:35â€&quot;42.31119115 ReavesB, BantingGVacuolar ATPase"/>
  <result pre="Cell Physiol. 2009;220:144â€&quot;54.19277980 RivinojaA, KokkonenN, KellokumpuIet al.Elevated Golgi pH in" exact="breast" post="and colorectal cancer cells correlates with the expression of"/>
  <result pre="2009;220:144â€&quot;54.19277980 RivinojaA, KokkonenN, KellokumpuIet al.Elevated Golgi pH in breast and" exact="colorectal cancer" post="cells correlates with the expression of oncofetal carbohydrate T-antigen."/>
  <result pre="RivinojaA, KokkonenN, KellokumpuIet al.Elevated Golgi pH in breast and colorectal" exact="cancer" post="cells correlates with the expression of oncofetal carbohydrate T-antigen."/>
  <result pre="hypersecretory diseases. Respir Care. 2007;52:1176â€&quot;93.17716385 RojekJM, PerezM, KunzSCellular entry of" exact="lymphocytic choriomeningitis" post="virus. J Virol. 2008;82:1505â€&quot;17.18045945 RouquetteM, PageS, BryantRet al.Xanthine oxidoreductase"/>
  <result pre="J Virol. 2008;82:1505â€&quot;17.18045945 RouquetteM, PageS, BryantRet al.Xanthine oxidoreductase is asymmetrically" exact="localized" post="on the outer surface of human endothelial and epithelial"/>
  <result pre="asymmetrically localized on the outer surface of human endothelial and" exact="epithelial" post="cells in culture. FEBS Lett. 1998;426:397â€&quot;401.9600274 SamjiTInfluenza A: understanding"/>
  <result pre="cells in culture. FEBS Lett. 1998;426:397â€&quot;401.9600274 SamjiTInfluenza A: understanding the" exact="viral" post="life cycle. Yale J Biol Med. 2009;82:153â€&quot;9.20027280 Sanchez-MartinezA, BeavanM,"/>
  <result pre="implications for rheumatology. Nat Rev Rheumatol. 2020;16:155â€&quot;66.32034323 SchwarzKBOxidative stress during" exact="viral" post="infection: a review. Free Radic Biol Med. 1996;21:641â€&quot;9.8891667 SeifartC,"/>
  <result pre="2005;203:27â€&quot;35.15694461 SencioV, BarthelemyA, TavaresLPet al.Gut dysbiosis during influenza contributes to" exact="pulmonary" post="pneumococcal superinfection through altered short-chain fatty acid production. Cell"/>
  <result pre="binding properties of soluble coronavirus spike (S1) proteins: differences between" exact="infectious" post="bronchitis virus and transmissible gastroenteritis virus. Viruses. 2013;5:1924â€&quot;33.23896748 ShepardsonK,"/>
  <result pre="properties of soluble coronavirus spike (S1) proteins: differences between infectious" exact="bronchitis" post="virus and transmissible gastroenteritis virus. Viruses. 2013;5:1924â€&quot;33.23896748 ShepardsonK, LarsonK,"/>
  <result pre="spike (S1) proteins: differences between infectious bronchitis virus and transmissible" exact="gastroenteritis" post="virus. Viruses. 2013;5:1924â€&quot;33.23896748 ShepardsonK, LarsonK, ChoHet al.A novel role"/>
  <result pre="influenza A virus nonstructural protein 1 in regulation of host" exact="susceptibility to" post="postinfluenza bacterial superinfections. Viral Immunol. 2019;32:131â€&quot;43.30822217 ShibataM, AokiH, TsurumiTet"/>
  <result pre="nonstructural protein 1 in regulation of host susceptibility to postinfluenza" exact="bacterial" post="superinfections. Viral Immunol. 2019;32:131â€&quot;43.30822217 ShibataM, AokiH, TsurumiTet al.Mechanisms of"/>
  <result pre="1 in regulation of host susceptibility to postinfluenza bacterial superinfections." exact="Viral" post="Immunol. 2019;32:131â€&quot;43.30822217 ShibataM, AokiH, TsurumiTet al.Mechanisms of uncoating of"/>
  <result pre="airway. Nature. 2006;440:435â€&quot;6.16554799 ShivakumarS, PanigrahiT, ShettyRet al.Chloroquine protects human corneal" exact="epithelial" post="cells from desiccation stress induced inflammation without altering the"/>
  <result pre="derÂ AaSet al.Influenza virus damages the alveolar barrier by disrupting" exact="epithelial" post="tight junctions. Eur Respir J. 2016;47:954â€&quot;66.26743480 SilvestriM, RossiGAMelatonin: its"/>
  <result pre="2016;47:954â€&quot;66.26743480 SilvestriM, RossiGAMelatonin: its possible role in the management of" exact="viral" post="infections â€&quot; a brief review. Ital J Pediatr. 2013;39:61.24090288"/>
  <result pre="SilvestriM, RossiGAMelatonin: its possible role in the management of viral" exact="infections" post="â€&quot; a brief review. Ital J Pediatr. 2013;39:61.24090288 SimmonsG,"/>
  <result pre="key player in the game against a wide range of" exact="viral" post="infections and non-infectious diseases. Adv Ther. 2019;36:1878â€&quot;905.31168764 SlootsTP, McErleanP,"/>
  <result pre="player in the game against a wide range of viral" exact="infections" post="and non-infectious diseases. Adv Ther. 2019;36:1878â€&quot;905.31168764 SlootsTP, McErleanP, SpeicherDJet"/>
  <result pre="Australian children. J Clin Virol. 2006;35:99â€&quot;102.16257260 SmallCL, ShalerCR, McCormickSet al.Influenza" exact="infection" post="leads to increased susceptibility to subsequent bacterial superinfection by"/>
  <result pre="Virol. 2006;35:99â€&quot;102.16257260 SmallCL, ShalerCR, McCormickSet al.Influenza infection leads to increased" exact="susceptibility to" post="subsequent bacterial superinfection by impairing NK cell responses in"/>
  <result pre="ShalerCR, McCormickSet al.Influenza infection leads to increased susceptibility to subsequent" exact="bacterial" post="superinfection by impairing NK cell responses in the lung."/>
  <result pre="new promise of an old drug for effective and safe" exact="cancer" post="therapies. Eur J Pharmacol. 2009;625:220â€&quot;33.19836374 SonD, ChungMHIn vitro synergism"/>
  <result pre="antibiotics against Orientia tsutsugamushi. Infect Chemother. 2014;46:182â€&quot;8.25298907 SpicklerARInfluenza. Flu, grippe," exact="avian influenza," post="grippe aviaire, fowl plaque, swine influenza, hog flu, pig"/>
  <result pre="2014;46:182â€&quot;8.25298907 SpicklerARInfluenza. Flu, grippe, avian influenza, grippe aviaire, fowl plaque," exact="swine influenza," post="hog flu, pig flu, equine influenza, canine influenzaFebruary 01,"/>
  <result pre="Flu, grippe, avian influenza, grippe aviaire, fowl plaque, swine influenza," exact="hog flu," post="pig flu, equine influenza, canine influenzaFebruary 01, 2016[cited 2020"/>
  <result pre="avian influenza, grippe aviaire, fowl plaque, swine influenza, hog flu," exact="pig flu," post="equine influenza, canine influenzaFebruary 01, 2016[cited 2020 April 07]."/>
  <result pre="07]. http://www.cfsph.iastate.edu/Factsheets/pdfs/influenza.pdf. SpiekermannS, LandmesserU, DikalovSet al.Electron spin resonance characterization of" exact="vascular" post="xanthine and NAD(P)H oxidase activity in patients with coronary"/>
  <result pre="of vascular xanthine and NAD(P)H oxidase activity in patients with" exact="coronary artery disease." post="Circulation. 2003;107:1383â€&quot;9.12642358 SrinivasanV, MohamedM, KatoHMelatonin in bacterial and viral"/>
  <result pre="vascular xanthine and NAD(P)H oxidase activity in patients with coronary" exact="artery disease." post="Circulation. 2003;107:1383â€&quot;9.12642358 SrinivasanV, MohamedM, KatoHMelatonin in bacterial and viral"/>
  <result pre="with coronary artery disease. Circulation. 2003;107:1383â€&quot;9.12642358 SrinivasanV, MohamedM, KatoHMelatonin in" exact="bacterial" post="and viral infections with focus on sepsis: a review."/>
  <result pre="artery disease. Circulation. 2003;107:1383â€&quot;9.12642358 SrinivasanV, MohamedM, KatoHMelatonin in bacterial and" exact="viral" post="infections with focus on sepsis: a review. Recent Pat"/>
  <result pre="disease. Circulation. 2003;107:1383â€&quot;9.12642358 SrinivasanV, MohamedM, KatoHMelatonin in bacterial and viral" exact="infections" post="with focus on sepsis: a review. Recent Pat Endocr"/>
  <result pre="Recent Pat Endocr Metab Immune Drug Discov. 2012;6:30â€&quot;9.22264213 SritharanMIron and" exact="bacterial" post="virulence. Indian J Med Microbiol. 2006;24:163â€&quot;4.16912433 StavrinidesJ, GuttmanDSMosaic evolution"/>
  <result pre="J Med Microbiol. 2006;24:163â€&quot;4.16912433 StavrinidesJ, GuttmanDSMosaic evolution of the severe" exact="acute" post="respiratory syndrome coronavirus. J Virol. 2004;78:76â€&quot;82.14671089 SteinhauerDA, deÂ laÂ"/>
  <result pre="Med Microbiol. 2006;24:163â€&quot;4.16912433 StavrinidesJ, GuttmanDSMosaic evolution of the severe acute" exact="respiratory" post="syndrome coronavirus. J Virol. 2004;78:76â€&quot;82.14671089 SteinhauerDA, deÂ laÂ TorreJC,"/>
  <result pre="Microbiol. 2006;24:163â€&quot;4.16912433 StavrinidesJ, GuttmanDSMosaic evolution of the severe acute respiratory" exact="syndrome" post="coronavirus. J Virol. 2004;78:76â€&quot;82.14671089 SteinhauerDA, deÂ laÂ TorreJC, HollandJJHigh"/>
  <result pre="SteinhauerDA, deÂ laÂ TorreJC, HollandJJHigh nucleotide substitution error frequencies in" exact="clonal" post="pools of vesicular stomatitis virus. J Virol. 1989;63:2063â€&quot;71.2539502 SteinhauerDARole"/>
  <result pre="HollandJJHigh nucleotide substitution error frequencies in clonal pools of vesicular" exact="stomatitis" post="virus. J Virol. 1989;63:2063â€&quot;71.2539502 SteinhauerDARole of hemagglutinin cleavage for"/>
  <result pre="that it forms a tetrameric channel. Virology. 1991;180:617â€&quot;24.1989386 SunK, MetzgerDWInfluenza" exact="infection" post="suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility"/>
  <result pre="channel. Virology. 1991;180:617â€&quot;24.1989386 SunK, MetzgerDWInfluenza infection suppresses NADPH oxidase-dependent phagocytic" exact="bacterial" post="clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus"/>
  <result pre="MetzgerDWInfluenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances" exact="susceptibility to" post="secondary methicillin-resistant Staphylococcus aureus infection. J Immunol. 2014;192:3301â€&quot;7.24563256 SuzukiA,"/>
  <result pre="suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to" exact="secondary" post="methicillin-resistant Staphylococcus aureus infection. J Immunol. 2014;192:3301â€&quot;7.24563256 SuzukiA, OkamotoM,"/>
  <result pre="Japan. Pediatr Infect Dis J. 2005;24:645â€&quot;6.15999010 SzczepanskiA, OwczarekK, BzowskaMet al.Canine" exact="respiratory" post="coronavirus, bovine coronavirus, and human coronavirus OC43: receptors and"/>
  <result pre="1949;39:171â€&quot;8.18111593 TektonidouMG, AndreoliL, LimperMet al.EULAR recommendations for the management of" exact="antiphospholipid syndrome" post="in adults. Ann Rheum Dis. 2019;78:1296â€&quot;1304.31092409 TeradaLS, PiermatteiD, ShibaoGNet"/>
  <result pre="TektonidouMG, AndreoliL, LimperMet al.EULAR recommendations for the management of antiphospholipid" exact="syndrome" post="in adults. Ann Rheum Dis. 2019;78:1296â€&quot;1304.31092409 TeradaLS, PiermatteiD, ShibaoGNet"/>
  <result pre="reactive oxygen species contribute to pathological inflammation during influenza A" exact="virus infection" post="in mice. Antioxid Redox Signal. 2020;32:929â€&quot;42.31190565 TongS, ZhuX, LiYet"/>
  <result pre="oxygen species contribute to pathological inflammation during influenza A virus" exact="infection" post="in mice. Antioxid Redox Signal. 2020;32:929â€&quot;42.31190565 TongS, ZhuX, LiYet"/>
  <result pre="evolution. Microbes Infect. 2011;13:479â€&quot;88.21276870 TsengYT, WangSM, HuangKJet al.Self-assembly of severe" exact="acute" post="respiratory syndrome coronavirus membrane protein. J Biol Chem. 2010;285:12862â€&quot;72.20154085"/>
  <result pre="Microbes Infect. 2011;13:479â€&quot;88.21276870 TsengYT, WangSM, HuangKJet al.Self-assembly of severe acute" exact="respiratory" post="syndrome coronavirus membrane protein. J Biol Chem. 2010;285:12862â€&quot;72.20154085 TyrrellDA,"/>
  <result pre="Infect. 2011;13:479â€&quot;88.21276870 TsengYT, WangSM, HuangKJet al.Self-assembly of severe acute respiratory" exact="syndrome" post="coronavirus membrane protein. J Biol Chem. 2010;285:12862â€&quot;72.20154085 TyrrellDA, AlmeidaJD,"/>
  <result pre="EldenLJ, NijhuisMet al.IL-10 is an important mediator of the enhanced" exact="susceptibility to" post="pneumococcal pneumonia after influenza infection. J Immunol. 2004;172:7603â€&quot;9.15187140 VargaZT,"/>
  <result pre="al.IL-10 is an important mediator of the enhanced susceptibility to" exact="pneumococcal pneumonia" post="after influenza infection. J Immunol. 2004;172:7603â€&quot;9.15187140 VargaZT, RamosI, HaiRet"/>
  <result pre="is an important mediator of the enhanced susceptibility to pneumococcal" exact="pneumonia" post="after influenza infection. J Immunol. 2004;172:7603â€&quot;9.15187140 VargaZT, RamosI, HaiRet"/>
  <result pre="HaiRet al.The influenza virus protein PB1-F2 inhibits the induction of" exact="type I" post="interferon at the level of the MAVS adaptor protein."/>
  <result pre="BergeronE, BenjannetSet al.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spread. Virol J. 2005;2:69.16115318 VisherE, WhitefieldSE, McCroneJTet al.The"/>
  <result pre="PLoS Pathog. 2016;12:e1005856.27571422 VivinoFB, CarsonsSE, FoulksGet al.New treatment guidelines for" exact="Sjogren's" post="disease. Rheum Dis Clin North Am. 2016;42:531â€&quot;51.27431353 VoroninaTAAntioxidant mexidol."/>
  <result pre="as a first line agent in the treatment of uncomplicated" exact="malaria" post="due to Plasmodium vivax in children and treatment practices"/>
  <result pre="Funct. 2017;8:2437â€&quot;43.28644504 YamamotoN, MatsuyamaS, HoshinoTet al.Nelfinavir inhibits replication of severe" exact="acute" post="respiratory syndrome coronavirus 2 in vitro. bioRxiv 2020.04.06.026476 [Preprint]2020;"/>
  <result pre="2017;8:2437â€&quot;43.28644504 YamamotoN, MatsuyamaS, HoshinoTet al.Nelfinavir inhibits replication of severe acute" exact="respiratory" post="syndrome coronavirus 2 in vitro. bioRxiv 2020.04.06.026476 [Preprint]2020; [cited"/>
  <result pre="YamamotoN, MatsuyamaS, HoshinoTet al.Nelfinavir inhibits replication of severe acute respiratory" exact="syndrome" post="coronavirus 2 in vitro. bioRxiv 2020.04.06.026476 [Preprint]2020; [cited 2020"/>
  <result pre="06]. Available from: biorxiv.org/content/10.1101/2020.04.06.026476v1. YamayaM, NishimuraH, NadineLKet al.Ambroxol inhibits rhinovirus" exact="infection" post="in primary cultures of human tracheal epithelial cells. Arch"/>
  <result pre="from: biorxiv.org/content/10.1101/2020.04.06.026476v1. YamayaM, NishimuraH, NadineLKet al.Ambroxol inhibits rhinovirus infection in" exact="primary" post="cultures of human tracheal epithelial cells. Arch Pharm Res."/>
  <result pre="al.Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal" exact="epithelial" post="cells. Arch Pharm Res. 2014;37:520â€&quot;9.23856970 YangB, YaoDF, OhuchiMet al.Ambroxol"/>
  <result pre="ZouZ, SunYet al.Anti-malaria drug chloroquine is highly effective in treating" exact="avian influenza" post="A H5N1 virus infection in an animal model. Cell"/>
  <result pre="chloroquine is highly effective in treating avian influenza A H5N1" exact="virus infection" post="in an animal model. Cell Res. 2013;23:300â€&quot;2.23208422 YinY, WunderinkRGMERS,"/>
  <result pre="is highly effective in treating avian influenza A H5N1 virus" exact="infection" post="in an animal model. Cell Res. 2013;23:300â€&quot;2.23208422 YinY, WunderinkRGMERS,"/>
  <result pre="Virol. 1984;51:497â€&quot;504.6431119 ZakaryanH, ArabyanE, OoAet al.Flavonoids: promising natural compounds against" exact="viral infection." post="Arch Virol. 2017;162:2539â€&quot;51.28547385 ZhangL, LiuYPotential interventions for novel coronavirus"/>
  <result pre="2017;162:2539â€&quot;51.28547385 ZhangL, LiuYPotential interventions for novel coronavirus in China: a" exact="systemic" post="review. J Med Virol. 2020;92:479â€&quot;90.32052466 ZhangR, WangX, NiLet al.COVID-19:"/>
  <result pre="Life Sci. 2020;250:117583.32217117 ZhaoP, SunL, XiongJet al.Semiaquatic mammals might be" exact="intermediate" post="hosts to spread avian influenza virus from avian to"/>
  <result pre="SunL, XiongJet al.Semiaquatic mammals might be intermediate hosts to spread" exact="avian influenza" post="virus from avian to human. Sci Rep. 2019;9:11641.31406229 ZhaoQ,"/>
  <result pre="LiS, XueFet al.Structure of the main protease from a global" exact="infectious" post="human coronavirus, HCoV-HKU1. J Virol.2008;82:8647â€&quot;55.18562531 ZhengJ, YamadaY, FungTSet al.Identification"/>
  <result pre="their functional impact on the replication and infectivity of coronavirus" exact="infectious" post="bronchitis virus in cell culture. Virology. 2018;513:65â€&quot;74.29035787 ZumlaA, ChanJF,"/>
  <result pre="functional impact on the replication and infectivity of coronavirus infectious" exact="bronchitis" post="virus in cell culture. Virology. 2018;513:65â€&quot;74.29035787 ZumlaA, ChanJF, AzharEIet"/>
 </snippets>
</snippetsTree>
